Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 12, 2008, Pages 4683-4689

  Won, Gu Kim ^a   Jong, Ho Yoon ^a   Won, Bae Kim ^a   Tae, Yong Kim ^a   Eui, Young Kim ^a   Jung, Min Kim ^b   Ryu, Jin Sook ^a   Gong, Gyungyub ^a   Suck, Joon Hong ^a   Young, Kee Shong ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROID HORMONE; THYROTROPIN;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; THYROID CARCINOMA; THYROIDECTOMY;

EID: 57349163504     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0962     Document Type: Article

References (26)

1. Spencer CA, Takeuchi M, Kazarosyan M 1996 Current status and performance goals for serum thyroglobulin assays. Clin Chem 42:164-173
2. Spencer CA 2004 Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. J Clin Endocrinol Metab 89:3702-3704
3. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR 2003 Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3-126
4. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142
5. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803
6. Pacini F, Mariotti S, Formica N, Elisei R, Anelli S, Capotorti E, Pinchera A 1988 Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumour outcome. Acta Endocrinol (Copenh) 119:373-380
7. Rubello D, Girelli ME, Casara D, Piccolo M, Perin A, Busnardo B 1990 Usefulness of the combined antithyroglobulin antibodies and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer. J Endocrinol Invest 13:737-742
8. Kumar A, Shah DH, Shrihari U, Dandekar SR, Vijayan U, Sharma SM 1994 Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma. Thyroid 4:199-202
9. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS, Nicoloff JT 1998 Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83:1121-1127
10. Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L, Pinchera A 2003 Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 139:346-351
11. Rubello D, Casara D, Girelli ME, Piccolo M, Busnardo B 1992 Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid cancer: a prospective study. J Nucl Med 33:1478-1480
12. Chung JK, Park YJ, Kim TY, So Y, Kim SK, Park DJ, Lee DS, Lee MC, Cho BY 2002 Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clin Endocrinol (Oxf) 57:215-221
13. Adil A, Jafri RA, Waqar A, Abbasi SA, Matiul H, Asghar AH, Jilani A, Naz I 2003 Frequency and clinical importance of anti-Tg auto-antibodies (ATG). J Coll Physicians Surg Pak 13:504-506
14. Quevedo I, Campino C, Rodriguez Portales JA, Arteaga E, Lopez JM, Campusano C, Gonzalez G, Fardella C, Slater J, Valdivia L, Poggi H, Foradori A, Velasco S 2002 -Anti thyroglobulin antibodies in the follow up of patients with differentiated thyroid cancer: residual or relapsing disease markers?]. Rev Med Chil 130:167-172
15. Gorges R, Maniecki M, Jentzen W, Sheu SN, Mann K, Bockisch A, Janssen OE 2005 Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. Eur J Endocrinol 153:49-55
16. Kim TY, Kim WB, Kim ES, Ryu JS, Yeo JS, Kim SC, Hong SJ, Shong YK 2005 Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 90:1440-1445
17. Team RDC 2007 R: A language and environment for stastical computing. Vienna: R Foundation for Statistical Computing
18. Hjiyiannakis P, Mundy J, Harmer C 1999 Thyroglobulin antibodies in differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 11:240-244
19. Ericsson UB, Christensen SB, Thorell JI 1985 A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid disease as measured with a sensitive solid-phase immunosorbent radioassay. Clin Immunol Immunopathol 37:154-162
20. Preissner CM, Klee GG, Krco CJ 1988 Nonisotopic "sandwich" immunoassay of thyroglobulin in serum by the biotin-streptavidin technique: evaluation and comparison with an immunoradiometric assay. Clin Chem 34:1794-1798
21. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP 1999 Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 126:1070-1076; discussion, 1076-1077
22. Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP 1999 Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84:458-463
23. Kebebew E, Treseler PA, Ituarte PH, Clark OH 2001 Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg 25:632-637
24. Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M 2000 Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 85:175-178
25. Pacini F, Capezzone M, Elisei R, Ceccarelli C, Taddei D, Pinchera A 2002 Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 87:1499-1501
26. Menendez Torre E, Lopez Carballo MT, Rodriguez Erdozain RM, Forga Llenas L, Goni Iriarte MJ, Barberia Layana JJ 2004 Prognostic value of thyroglobulin serum levels and 131I whole-body scan after initial treatment of low-risk differentiated thyroid cancer. Thyroid 14:301-306